ISRG vs RTX: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and RTX Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Intuitive Surgical, Inc. · Healthcare
$451.29
+130.4% upside to fair value
Grade B
High Quality
VS
RTX Corporation · Industrials
$172.90
-21.3% upside to fair value
Grade D
QuantHub Verdict
ISRG has more upside to fair value
(+130.4%).
RTX trades at a lower forward P/E
(32.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
RTX |
| Current Price |
$451.29 |
$172.90 |
| Fair Value Estimate |
$1,039.74 |
$136.05 |
| Upside to Fair Value |
+130.4%
|
-21.3%
|
| Market Cap |
$160.3B |
$232.8B |
| Forward P/E |
53.8x
|
32.1x
|
| EV / EBITDA |
40.5x
|
19.2x
|
| Price / Sales |
15.2x
|
2.6x
|
| Price / FCF |
64.3x
|
27.9x
|
| Revenue Growth YoY |
+23.0%
|
+8.7%
|
| Gross Margin |
66.3%
|
20.2%
|
| Operating Margin |
30.5%
|
10.4%
|
| Return on Equity |
17.0%
|
11.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.55%
|
3.59%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings gro…
Accumulation Zones
| Metric |
ISRG |
RTX |
| Zone Low |
$779.81 |
$102.04 |
| Zone High |
$883.78 |
$115.64 |
| In Buy Zone? |
Yes
|
No
|